Immuron (IMRN) Total Liabilities (2016 - 2025)
Immuron (IMRN) posted quarterly Total Liabilities of $20607.9 for Q3 2025, down 27.45% year-on-year from $28405.2 in Q3 2024, and down 98.58% on a QoQ basis from $1.5 million in Q2 2025.
Immuron (IMRN) Total Liabilities (2016 - 2025) Analysis & Trends
Immuron (IMRN) has reported Total Liabilities for 10 consecutive years, with $20607.9 the latest figure, recorded in Q3 2025.
- Quarterly Total Liabilities fell 27.45% year-over-year to $20607.9 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $20607.9 (down 27.45% YoY) and the FY2025 annual result came in at $20607.9, down 27.45% from the prior year.
- Total Liabilities retreated to $20607.9 in Q3 2025 per IMRN's latest filing, from $1.5 million in the prior quarter.
- Over the last five years, Total Liabilities for IMRN reached as high as $2.0 million in Q2 2024 and fell as low as $8472.1 in Q4 2021.
- A 5-year average of $838492.5 and a median of $1.2 million in 2022 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2022 — Total Liabilities surged 13891.22% — and 2023, when it sank 98.6%.
- Year by year, Total Liabilities stood at $8472.1 in 2021, then jumped by 13891.22% to $1.2 million in 2022, then sank by 98.6% to $16640.1 in 2023, then jumped by 7667.75% to $1.3 million in 2024, then slumped by 98.41% to $20607.9 in 2025.
- According to Business Quant data, Total Liabilities over the past three periods registered $20607.9, $1.5 million, and $1.3 million for Q3 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 60.46 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 177.22 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 3.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 7.33 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 7.12 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.45 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.48 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.62 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 753.82 Mn |
| 10 | Immuron | 270.20 Mn | 258.54 Mn | - | 20,607.86 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 2, 2025 | 20,607.86 |
| Jun 30, 2025 | 1.46 Mn |
| Dec 31, 2024 | 1.29 Mn |
| Sep 9, 2024 | 28,405.25 |
| Jun 30, 2024 | 2.01 Mn |
| Dec 31, 2023 | 16,640.07 |
| Sep 28, 2023 | 1.67 Mn |
| Jun 30, 2023 | 23,713.46 |
| Dec 31, 2022 | 1.19 Mn |
| Aug 31, 2022 | 1.19 Mn |
| Jun 30, 2022 | 1.19 Mn |
| Dec 31, 2021 | 8,472.05 |
| Jun 30, 2021 | 817,842.78 |
| Jun 30, 2020 | 394,249.92 |
| Dec 31, 2019 | 5.58 Bn |
| Jun 30, 2019 | 1.21 Mn |
| Dec 31, 2018 | 521,234.00 |
| Jun 30, 2018 | 803,338.00 |
| Dec 31, 2017 | 828,980.65 |
| Jun 30, 2017 | 1.71 Mn |